Latest News & Updates
Breaking News
4 minutes ago
Simantini Singh Deo
Other trending news you may like to read
Biofrontera Completes FDA NDA And IND Transfers For Ameluz® And RhodoLED® Lamps, Gains Full US Regulatory And IP Control
Biofrontera finalizes FDA and IP transfers for Ameluz and RhodoLED, strengthening U.S. regulatory control and market position.
Simantini Singh Deo
Sangamo Therapeutics Begins Rolling FDA Submission For ST-920 Gene Therapy To Treat Adults With Fabry Disease
Sangamo initiates a rolling FDA BLA for ST-920, a one-time gene therapy targeting the underlying cause of Fabry disease.
Simantini Singh Deo
vTv Therapeutics Submits Phase 2 Cadisegliatin Study Protocol To Abu Dhabi DOH, Partnering With M42’s IROS For 12-Month Insulin Adjunct Trial
vTv Therapeutics plans a 12-month Phase 2 trial of cadisegliatin as an oral add-on to insulin in type 2 diabetes patients.
Simantini Singh Deo
Takeda’s Oral TYK2 Inhibitor Zasocitinib Delivers Positive Phase 3 Results In Plaque Psoriasis; Shows Strong Efficacy And Skin Clearance
Takeda’s Phase 3 trials show once-daily zasocitinib delivers rapid and deep skin clearance in moderate-to-severe plaque psoriasis.
Vaibhavi M.
